SCHEMBL24280183

SCHEMBL24280183

c1ccc(-c2nc(-c3ccc(-c4ccc5c(ccc6ccccc65)c4)cc3)nc(-c3cccc(-c4nc5sc6ccccc6c5c5ccccc45)c3)n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ ERBB2 P04626 1/20 0.33
▸ FYN P06241 1/20 0.33
▸ MAOA P21397 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ AHR P35869 1/20 0.33
▸ F9 P00740 2/20 0.32
▸ ADORA2A P29274 1/20 0.32
▸ ADORA1 P30542 1/20 0.32
▸ NQO1 P15559 1/20 0.32
▸ NQO2 P16083 1/20 0.32
▸ CYP1A1 P04798 1/20 0.32
▸ CYP1B1 Q16678 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ RECQL P46063 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24281767 0.95 MEN1 (0.38) MEN1KMT2AATMCYP1A2ERBB2
SCHEMBL24280525 0.94 MEN1 (0.34) MEN1KMT2ACYP1A2ERBB2FYN
SCHEMBL19106437 0.90 ADORA2A (0.36) MEN1KMT2AATMCYP1A2ERBB2
SCHEMBL22274333 0.90 MEN1 (0.35) MEN1KMT2AATMADORA2AADORA1
SCHEMBL22273878 0.89 MEN1 (0.36) MEN1KMT2AATMMAOAF9
SCHEMBL24280189 0.88 CYP11B1 (0.35) MEN1KMT2AATMF9ADORA2A
SCHEMBL19106414 0.88 CYP1A2 (0.35) MEN1KMT2AATMCYP1A2ERBB2
SCHEMBL22274326 0.88 MEN1 (0.36) MEN1KMT2AATMADORA2AADORA1
SCHEMBL18859626 0.88 NQO2 (0.38) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL19106423 0.87 CYP1A2 (0.35) MEN1KMT2AATMCYP1A2ERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220085298-A1 COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE LT MATERIALS CO., LTD. (KR) 2022-03-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220085298-A1 COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE ALDH1A2, OXER1, AOX1 MEN1 3195/4885KMT2A 3054/4885ATM 3762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback